IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 20 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $216,000 | -2.7% | 77,574 | -23.4% | 0.14% | +5.2% |
| Q2 2018 | $222,000 | +14.4% | 101,239 | -8.2% | 0.13% | +15.5% |
| Q1 2018 | $194,000 | +3.2% | 110,249 | -0.2% | 0.12% | +5.5% |
| Q4 2017 | $188,000 | -5.1% | 110,449 | -10.3% | 0.11% | -0.9% |
| Q3 2017 | $198,000 | -45.5% | 123,119 | +8.6% | 0.11% | -44.2% |
| Q2 2017 | $363,000 | -27.4% | 113,324 | -5.5% | 0.20% | -30.7% |
| Q1 2017 | $500,000 | +119.3% | 119,922 | +31.4% | 0.29% | +103.5% |
| Q4 2016 | $228,000 | +81.0% | 91,277 | +175.8% | 0.14% | +76.2% |
| Q3 2016 | $126,000 | +7.7% | 33,097 | +6.4% | 0.08% | +5.3% |
| Q2 2016 | $117,000 | – | 31,107 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 860,500 | $3,588,000 | 1.79% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 694,363 | $2,895,000 | 0.90% |
| MARATHON ASSET MANAGEMENT LP | 792,434 | $3,305,000 | 0.36% |
| CORRADO ADVISORS, LLC | 119,922 | $500,000 | 0.29% |
| BARD ASSOCIATES INC | 305,500 | $1,275,000 | 0.12% |
| Granite Investment Partners, LLC | 297,297 | $1,239,000 | 0.08% |
| WEALTHSOURCE PARTNERS, LLC | 30,000 | $125,000 | 0.05% |
| Apollo Management Holdings, L.P. | 100,000 | $417,000 | 0.01% |
| ARDSLEY ADVISORY PARTNERS LP | 10,000 | $42,000 | 0.01% |
| Virtu KCG Holdings LLC | 31,222 | $130,000 | 0.00% |